ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,147,000 | -23.2% | 57,758 | +15.3% | 0.01% | +22.2% |
| Q1 2022 | $1,494,000 | -0.2% | 50,085 | -22.1% | 0.01% | +12.5% |
| Q4 2021 | $1,497,000 | +14.7% | 64,288 | +53.7% | 0.01% | -11.1% |
| Q3 2021 | $1,305,000 | +22.7% | 41,818 | +38.2% | 0.01% | +28.6% |
| Q2 2021 | $1,064,000 | -38.8% | 30,253 | -38.7% | 0.01% | -41.7% |
| Q1 2021 | $1,739,000 | +514.5% | 49,328 | +553.1% | 0.01% | +300.0% |
| Q4 2020 | $283,000 | – | 7,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |